Clindamycin
Back to searchMolecule Structure
Scientific Name
Clindamycin
Description of the Drug
Clindamycin is a lincosamide antibiotic used to treat serious infections caused by susceptible anaerobic, streptococcal, staphylococcal, and pneumococcal bacteria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01190
http://www.drugbank.ca/drugs/DB01190
Brand Name(s)
Antirobe, Cleocin, Cleocin T, Sobelin
Company Owner(s)
Epic Pharma Llc, Micro Labs Ltd, Teva Pharmaceuticals Usa Inc, Sun Pharmaceutical Industries Ltd, Watson Laboratories Inc, Aurobindo Pharma Ltd, Pharmacia And Upjohn Co, Lannett Holdings Inc, Mylan Pharmaceuticals Inc, Lannett Co Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3154 | ||
DrugBank | DB01190 | ||
PubChem: Thomson Pharma | 14880545 | 14905082 | |
PubChem | 446598 | ||
Nikkaji | J9.300I | ||
PDBe | CLY | ||
EPA CompTox Dashboard | DTXSID2022836 | ||
DrugCentral | 678 | ||
Brenda | 6919 | ||
ChemicalBook | CB4399999 | ||
Guide to Pharmacology | 10607 | ||
rxnorm | CLINDAMYCIN HYDROCHLORIDE | ANTIROBE | CLINDAMYCIN |
ZINC | ZINC000004038341 |